Ovarian steroids, stem cells and uterine leiomyoma: therapeutic implications. - sprookjes - yvandenbroek - TriplyDB

Ovarian steroids, stem cells and uterine leiomyoma: therapeutic implications.

Ovarian steroids, stem cells and uterine leiomyoma: therapeutic implications.

http://www.wikidata.org/entity/Q34437666

about

The Important Roles of Steroid Sulfatase and Sulfotransferases in Gynecological Diseases Recent scientific advances in leiomyoma (uterine fibroids) research facilitates better understanding and management Mediator kinase module and human tumorigenesis Patients with uterine leiomyoma exhibit a high incidence but low mortality rate for breast cancer.Recent Advances in Uterine Fibroid Etiology.Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.Primary Human Uterine Leiomyoma Cell Culture Quality Control: Some Properties of Myometrial Cells Cultured under Serum Deprivation Conditions in the Presence of Ovarian Steroids.Circulating Sex Hormones and Risk of Uterine Fibroids: Study of Women's Health Across the Nation (SWAN).Epidemiology of Uterine Fibroids: From Menarche to Menopause.Endocrinology of uterine fibroids: steroid hormones, stem cells, and genetic contribution.Ulipristal acetate before high complexity endoscopic (hysteroscopic, laparoscopic) myomectomy - a mini-review.Urological complications of uterine leiomyoma: a review of literature.Targeting leiomyomas with all-trans-retinoic acid at phosphoinositide 3-kinase pathway suppression: Effective roles of β-catenin and of signaling interactions.Endocrine-disrupting chemicals and uterine fibroids.Uterine fibroid management: from the present to the future.Developmental Exposure to Endocrine Disruptors Expands Murine Myometrial Stem Cell Compartment as a Prerequisite to Leiomyoma Tumorigenesis.Epigenetic and genetic landscape of uterine leiomyomas: a current view over a common gynecological disease.Pathobiology of myomatosis uteri: the underlying knowledge to support our clinical practice.The role of levonorgestrel intrauterine systems in the treatment of symptomatic fibroids.Expression Levels of Myostatin and Matrix Metalloproteinase 14 mRNAs in Uterine Leiomyoma are Correlated With Dysmenorrhea.Paracrine Pathways in Uterine Leiomyoma Stem Cells Involve Insulinlike Growth Factor 2 and Insulin Receptor A.Seasonal expression of P450arom and estrogen receptors in scented glands of muskrats (Ondatra zibethicus).Porcine intestinal lymphoid tissues synthesize estradiol.Fibroid Complications in Pregnancy

P2860

Q26765913-01B3AEB7-AD6D-445C-8F30-63002B48F3A0 Q26799918-364C0DC8-763A-4DC4-A1A0-95F0F92C951A Q26800203-74088119-CD5D-4C25-B4B7-80F9405E3A8C Q33779337-121E9E28-C8ED-4FA0-8164-94486AD4D97D Q33852886-C2C1DE68-8CC7-444D-85AA-0F38240E2A57 Q35944399-D63F3199-1F1F-4789-A6DC-F985C012797B Q36071259-B43BC889-C962-4C11-A350-F100093AB9C2 Q36431640-A8A611C4-9306-4076-AFBE-ECDDCC0CF707 Q36522644-807842DE-0FD3-4F35-95BC-B2584FF05D7E Q36525065-C31D41DF-F322-44A4-A469-6496B6DD8BF2 Q37668496-27B7F762-9A68-4DBC-B3AC-28992A727C4B Q38752901-88713990-DF67-4BDF-AE53-75DDEBA94DF8 Q38761092-AEC5AE3D-0DCB-483F-A98D-C962FDB59FA1 Q38828590-49DFE9A0-6426-43B0-8BE9-3B3623954C5B Q38837038-B3C27DF4-21CE-4049-ADB2-2CA7B9D7FA1C Q39292947-52689690-F72C-480D-A437-0CBA58E79F4D Q47850947-BC9162FB-DEF0-4A9C-8C06-107C70A3ED54 Q48137294-4F85846A-67F3-46F8-AE84-A4C806933016 Q50281278-ADEF739D-D0FF-4E3C-948B-6764448C4A45 Q50579772-9966AD9A-F4A7-40C2-9687-3DA208843444 Q50785220-6C1D7264-2D42-4CB9-A2D3-F63A0E0FF0B9 Q50980516-FE2DF89D-3449-4420-8CFD-687BA85898BA Q53081474-779A0273-A5FC-40DF-AAD1-EFED19725D75 Q53101697-1CA59FC9-2AB7-4911-B783-FF92473BB813

P2860

Ovarian steroids, stem cells and uterine leiomyoma: therapeutic implications.

http://www.wikidata.org/entity/Q34437666

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Ovarian steroids, stem cells and uterine leiomyoma: therapeutic implications.

@ast

Ovarian steroids, stem cells and uterine leiomyoma: therapeutic implications.

@en

Ovarian steroids, stem cells and uterine leiomyoma: therapeutic implications.

@nl

type

label

Ovarian steroids, stem cells and uterine leiomyoma: therapeutic implications.

@ast

Ovarian steroids, stem cells and uterine leiomyoma: therapeutic implications.

@en

Ovarian steroids, stem cells and uterine leiomyoma: therapeutic implications.

@nl

prefLabel

Ovarian steroids, stem cells and uterine leiomyoma: therapeutic implications.

@ast

Ovarian steroids, stem cells and uterine leiomyoma: therapeutic implications.

@en

Ovarian steroids, stem cells and uterine leiomyoma: therapeutic implications.

@nl

P1433

Q34437666-2E9AA0F6-C426-4219-89B8-DC6A8BE5E1DF

P1476

Q34437666-5EF88675-E8D7-46B1-9089-A3A59C326911

P2093

Q34437666-08237960-98F0-471A-9D03-31F2E463E88E

Q34437666-3D33FB20-E0A9-410B-B346-90064924EA14

Q34437666-42262BFF-6AF1-4B31-8504-AB0347F6ED42

Q34437666-64872475-8842-428F-8518-6BCEE76718F8

Q34437666-8F80C914-64A8-40C2-A9A4-02DDC1D34B7A

Q34437666-C7A6A270-42D4-4074-BB34-1AEB53535B82

Q34437666-CF9F0AAE-7AB1-450E-9040-4D0B52D5A788

P2860

Q34437666-003188C2-0318-4D92-878C-D2C9BF0D7A52

Q34437666-003C7796-12B4-4DDF-8AEC-1C181A10839D

Q34437666-023126DE-FB4B-4613-95BD-E6F80AC9ADB2

Q34437666-05EF5F5C-F5C1-49BA-BBB8-3DDE688B0CCD

Q34437666-06C2F752-DBD1-44CB-839B-3C6297FC2744

Q34437666-0A21119D-F4F6-4EDB-8932-A44F941735CF

Q34437666-0A2F02DC-2230-4B24-BD38-E3E0ACDE676E

Q34437666-0DC72682-42D6-47C8-9EB3-02541F6D4845

Q34437666-0E0561DF-6771-48DF-861C-CE58B9E7C576

Q34437666-0EE0CBA3-6F5E-46B2-967F-584BC38BC8D4

P304

Q34437666-C1E6770B-064B-4E7C-8F4F-26DB27A22CC4

P31

Q34437666-44d89a87-0215-4605-a59c-a737bcd153e0

Q34437666-6A2D20D1-899A-4E76-9306-E589BE4B1BD4

P356

Q34437666-5CD98F46-8AB6-4EED-A7DE-4BB08C0F816D

P433

Q34437666-DA09C2B8-8AFF-482E-ADFA-7410A5D5FC88

P478

Q34437666-1D7BE561-A5EE-4004-AE89-D76A161100DA

P50

Q34437666-305AE9BB-3C86-453E-A7E2-9EC511692C56

Q34437666-5EEB9082-1860-4861-B8D3-66DDBCDD5AF0

Q34437666-7AACB416-AB0A-4326-9D72-D1832DA48279

Q34437666-D6672776-F467-43FA-8712-151EB1B4CB0F

P577

Q34437666-7D837FA2-67C5-435F-B3F9-0A1FA5F73ED3

P5875

Q34437666-6CE60435-7586-4834-8C69-E9A158D2831B

P698

Q34437666-70F06345-3A30-4037-8561-C0FA25AFD581

P932

Q34437666-42A87D15-EF4B-4567-9286-8F532A3B0B9B

P356

P1433

Human Reproduction Update

P1476

Ovarian steroids, stem cells and uterine leiomyoma: therapeutic implications

@en

P2093

Antonia Navarro

http://www.w3.org/2001/XMLSchema#string

Erica E Marsh

http://www.w3.org/2001/XMLSchema#string

J Julie Kim

http://www.w3.org/2001/XMLSchema#string

Jian-Jun Wei

http://www.w3.org/2001/XMLSchema#string

John S Coon

http://www.w3.org/2001/XMLSchema#string

Ping Yin

http://www.w3.org/2001/XMLSchema#string

Serdar E Bulun

http://www.w3.org/2001/XMLSchema#string

P2860

Human leiomyoma smooth muscle cells show increased expression of transforming growth factor-beta 3 (TGF beta 3) and altered responses to the antiproliferative effects of TGF beta

Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B

1,25-dihydroxyvitamin D3 treatment shrinks uterine leiomyoma tumors in the Eker rat model

High aromatase expression in uterine leiomyoma tissues of African-American women

Medical treatment of uterine leiomyoma

A structural and in vitro characterization of asoprisnil: a selective progesterone receptor modulator

The nuclear receptor superfamily: the second decade

Stem cells: units of development, units of regeneration, and units in evolution

Asoprisnil (J867): a selective progesterone receptor modulator for gynecological therapy

P304

1-12

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/HUMUPD/DMU048

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P50

Matthew T Dyson

Debabrata Chakravarti

Molly B Moravek

P577

2014-09-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

265515583

http://www.w3.org/2001/XMLSchema#string

P698

25205766

http://www.w3.org/2001/XMLSchema#string

P932

4255606

http://www.w3.org/2001/XMLSchema#string